Shannon Brode, MPH, Product Manager, Health Technology Briefs

Shannon Brode joined Hayes, Inc. in 2013 as a Medical Research Analyst with the Medical Technology Directory product line. She currently serves as the Product Manager of the Health Technology Brief product line which is tasked with writing methodologically rigorous health technology assessments on new and emerging health technologies, devices, procedures, and pharmaceuticals. Shannon brings 9 years of experience in writing health technology assessments, performing systematic literature searches, and evaluating the quality of evidence. Her systematic review expertise includes evaluating the comparative effectiveness of nonpharmacological treatments for treatment resistant depression and characteristics of long-term care settings for people with dementia both of which were undertaken for the Agency for Healthcare Research and Quality (AHRQ) through the Research Triangle Institute-University of North Carolina at Chapel Hill Evidence-Based Practice Center. She has also been involved in stakeholder engagement and needs assessment projects, has managed projects requiring strict adherence to contract deadlines, supported research and dissemination activities of research projects, and coordinated participant recruitment and data analysis of a genotype-guided warfarin dosing clinical trial. Her efforts while at Hayes have been focused not only on writing and editing health technology assessments for the Directory and Health Technology Brief product lines, but also translating AHRQ comparative effectiveness reviews into continuing education credits for health professionals.

Recent Posts

HHS Secretary Recommends Screening for Spinal Muscular Atrophy

On July 2, 2017, Health and Human Services (HHS) Secretary Alex Azar approved a recommendation for genetic screening of all newborns for spinal muscular atrophy (SMA). The approval follows a recommendation from the Advisory Committee on Heritable Disorders in Newborns and Children to add screening for SMA to the Recommended Uniform Screening Panel (RUSP). The RUSP is a list of disorders that HHS recommends states screen for as part of their state universal newborn screening programs.

Read More

Topics: Spinal Muscular Atrophy

Can Health Technology Assessments Save Payers and Consumers Billions?

shutterstock_120066145.jpgOn September 30, 2016, the Office of Inspector General (OIG) in the U.S. Department of Health and Human Services (HHS) released a memorandum. In it, Daniel Levinson details the initial results of an ongoing audit of Medicare costs incurred due to defective or recalled medical devices. For seven devices, which are as yet unnamed, the audit revealed $1.5 billion in Medicare payments, along with $140 million in copays and deductibles paid directly as out-of-pocket beneficiary expenses for services and procedures involving these failed or recalled devices.

Read More

Sign up to receive updates from our blog

Our latest articles

New Call-to-action